LongCovid
“The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking despite numerous case reports and small series. Two studies that use large cohorts now highlight that SARS-CoV-2 infection is linked to a substantially increased risk of developing a diverse spectrum of new-onset autoimmune diseases.”
New article published in Nature Reviews Rheumatology:
High risk of autoimmune diseases after COVID-19 | Nature Reviews Rheumatology
📅 24/04 – 30/04/2024 Let’s celebrate World Immunization Week 2024! 🌍 The COVID-19 pandemic has marked the beginning of a new era for vaccines & immunization and has…
Given the rapidly developing Covid-19 situation in China and a lack of reliable data, the #EUHealthSecurity Committee has issued an opinion emphasising the need for a common, phased…
After one year of its official beginning, today and tomorrow the Long COVID project holds its 12-month Consortium Meeting in Basel & Zurich, Switzerland. During these two days…
On 5 January 2023, the EU-funded projects COVIRNA, ENVISION and COVend held a joint webinar on ’Addressing unmet clinical needs, practices and patient outcomes: the impact of EU-funded projects‘. Experts presented…